Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

University Hospital, Rouen

Status: Completed

Conditions: Acquired Haemophilia; Register

Study type: Observational

Funder types: Other

Identifiers

NCT00213473

2001/001/HP

Details and patient eligibility

About

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer > 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

Enrollment: 81 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Factor VIIIc < 30% and Factor VIII inhibitor > 1 u Bethesda

Exclusion criteria

• absence and signed consent, haemophilia A